College of Medical Sciences Teaching Hospital. Nepal Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04494126
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

College of Medical Sciences Teaching Hospital. Nepal

Active Ingredients

Drugs in Phase 4 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1